Sunitinib attenuates reactive MDSCs enhancing anti-tumor immunity in HNSCC
Jie Liu, Wen‐Ping Lin, Wen Su, Zhi‐Zhong Wu, Qi‐Chao Yang, Shuo Wang, Ting‐Guan Sun, Cong‐Fa Huang, Xiaolong Wang, Zhi‐Jun Sun, Xiaolong Wang, Zhi‐Jun Sun
Topics & Concepts
Cancer researchTumor microenvironmentEZH2MedicineSunitinibTumor progressionImmune systemCombination therapyImmune checkpointImmunotherapyPharmacologyImmunologyCancerInternal medicineBiologyEpigeneticsGeneBiochemistryImmune cells in cancerCancer Immunotherapy and BiomarkersCancer Cells and Metastasis